Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

BEADI - The Bliss Cluster Randomised Control Trial on the Effects of Active Dissemination of Information (BEADI)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Confidential Enquiry into Maternal and Child Health.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Confidential Enquiry into Maternal and Child Health
ClinicalTrials.gov Identifier:
NCT00831168
First received: January 27, 2009
Last updated: NA
Last verified: January 2009
History: No changes posted

January 27, 2009
January 27, 2009
October 2005
March 2009   (final data collection date for primary outcome measure)
Assess whether an innovative 'active' strategy for the dissemination of neonatal research findings, recs and national guidelines is more likely to lead to changes in policy and practice than the traditional,passive forms of dissemination in the UK. [ Time Frame: 3 years ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
BEADI - The Bliss Cluster Randomised Control Trial on the Effects of Active Dissemination of Information (BEADI)
The Bliss Cluster Randomised Control Trial on the Effects of Active Dissemination of Information on Outcomes of Premature Babies.

BEADI is a dissemination trial, on standards of care of premature babies. The main objective of BEADI is to assess whether an innovative 'active' strategy for the dissemination of neonatal information (evidence reviews, interactive training workshop, benchmarking and feedback, and ongoing support) is more likely to lead to changes in policy and practice than the traditional (more passive) forms of dissemination in English neonatal units.

BEADI will focus on three areas of neonatal care for premature (22+0 to 26+6 weeks' gestation) babies born in England: timing of surfactant therapy, staffing for resuscitation at delivery, and temperature control (in line with the main Project 27/28 findings ). However, the approach is applicable to a wide variety of clinical policies and practice.

The BEADI study has been granted ethical approval by MREC to use a subset of data collected by EPICure2 up until 31st December 2006 (pre-intervention data). For the post-intervention data, ethical approval has been granted for CEMACH to continue data collection against the three clinical areas using a subset of data items captured in the PN:E2 form, for the three month period between 1st January - 31st March 2007. Local research and development departments of each trust have also been contacted.

Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Premature Babies
Behavioral: Effects of Active Dissemination
No medical intervention involved. It is purely information based.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
200
March 2009
March 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Hospital staff : Lead neonatologist for clinical governance in each maternity hospital in England.
  • Babies born in England before 27 weeks gestation between January 2006 - 31st March 2007
Both
22 Weeks to 27 Weeks
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00831168
BEADI2005
No
Richard Congdon, CEMACH
Confidential Enquiry into Maternal and Child Health
Not Provided
Principal Investigator: Dominique Acolet Confidential Enquiry into Maternal and Child Health
Confidential Enquiry into Maternal and Child Health
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP